Novavax Inc
NVAX• NASDAQ
$7.97
+0.05+0.63%
In the past 24 hours
No 24-hour summary has been generated yet.
Financial highlights
Latest saved period: December 2025 · 2025-12-31
Revenue
$147.14M
Net income
$17.53M
Free cash flow
-$41.55M
Diluted EPS
—
Gross margin
82.87%
Profit margin
11.91%
Assets
$1.18B
Cash
$240.63M
Valuation
Market Cap$1.30B
Enterprise Value$840.66M
PE (TTM)3.13
PE (Fwd)2.58
Price to Sales1.16
EV / EBITDA1.71
Price to Book33.20
PEG Ratio1.32
Cash Flow
FCF Yield-19.24%
FCF / Share-$1.45
SBC-Adj FCF Yield-22.01%
SBC-Adj FCF / Share-$1.66
SBC Impact+14.37%
Margins & Growth
Gross Margin93.67%
Operating Margin50.14%
Profit Margin39.19%
Quarterly Rev YoY+66.61%
Quarterly EPS YoY+121.63%
Balance
Cash$240.63M
Debt$246.72M
Net Debt$6.09M
Current Ratio2.13
Debt / Equity—
Dividend
Dividend Yield—
Payout Ratio—
DPS (TTM)$0.00
Last Ex-Date—
Dividend history
Cash dividends by ex-date, not an investment recommendation.
No saved cash dividend records are available for this instrument yet.
Price
-96.21%
Jul 19, 2021 - Apr 29, 2026 · 1,201 daily points
Revenue
↑ 4257.1%Net Income
↑ 167.8%Free Cash Flow
↓ 78.9%Diluted EPS
No data
Quick Stats
Open
$7.83
Day High
$7.99
Day Low
$7.71
Prev Close
$7.92
Market Cap
—
Volume
2,824,017
Novavax Inc (NVAX) analysis
Wrqti brings Novavax Inc data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Available price
$7.97
Market cap
$1.30B
PE ratio
3.13
Price to book
33.20
Profit margin
39.19%
FCF yield
-19.24%
Stocks related to Novavax Inc
Companies in the same sector you can compare with Novavax Inc: